Search Login Register

dorzolamide (Trusopt) Summary

Description: topically effective ocular hypotensive carbonic anhydrase inhibitor; RN refers to mono-HCl (4S-trans)-isomer

Also Known As: Trusopt; dorzolamide hydrochloride; 4-ethylamino-5,6-dihydro-6-methyl-7,7-dioxide-4H-thieno(2,3-b)thiopyran-2-sulfonamide; 5,6-dihydro-4-ethylamino-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide; Cahill May Roberts brand of dorzolamide hydrochloride Show All >>

Networked: 376 relevant articles (68 outcomes, 109 trials/studies) for this Drug

Key Diseases for which dorzolamide is Relevant

  1. Glaucoma : 27 outcomes 37 studies in 161 results
  2. Open-Angle Glaucoma (Glaucoma, Open Angle) : 26 outcomes 57 studies in 157 results
  3. Ocular Hypertension (Glaucoma, Suspect) : 24 outcomes 39 studies in 103 results
  4. Macular Edema : 6 outcomes 2 studies in 12 results
  5. Retinitis Pigmentosa (Pigmentary Retinopathy) : 6 outcomes in 10 results
Show All >>

Drugs Related to dorzolamide

  1. Timolol (Blocadren)
  2. latanoprost (Xalatan)
  3. brimonidine (Alphagan)
  4. Carbonic Anhydrases (Carbonic Anhydrase)
  5. brinzolamide (Azopt)
  6. travoprost (Travatan)
  7. Acetazolamide (Diamox)
  8. dorzolamide (Trusopt)
  9. hydroxide ion
  10. Ophthalmic Solutions (Eye Drops)
Show All >>

Therapies Related to dorzolamide

  1. Lasers (Laser)
  2. Trabeculectomy (Trabeculoplasty)
  3. Phacoemulsification
  4. Topical Administration
  5. Vitrectomy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.